Effect of Rasnadi Guggul and Shallaki in management of Sandhigat vata(Osteoarthritis)

â??A COMPARATIVE CLINICAL STUDYOF RASNADI GUGGUL AND SHALLAKI IN MANAGEMENT OF SANDHIGAT VATAâ??

Status

Active, not recruiting

Phases

Phase 1Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2019/03/018021

Enrollment

Registered

2019-03-11

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M159- Polyosteoarthritis, unspecified

Interventions

Intervention1: Rasnadi guggul 500 mg: Rasnadi guggul will be made in pharmacy and standardisation will be done from recognised institute. Rasnadi guggul 500 mg 2tabs twice a day for 45 days Control In

Eligibility

Inclusion criteria

Inclusion criteria: Patients diagnosed with osteoarthritis(Sandhigat vata) 1)Age: 30 years to 70 years of age 2)Gender: Male & female 3)Signs and symptoms of pain, swelling, crepitus, tenderness, stiffness, painful movements etc. 4)Patients without any anatomical deformity.

Exclusion criteria

Exclusion criteria: 1)Patients below 30 years and above 70 yrs of age. 2)Patients suffering from uncontrolled diabetes, Rheumatoid arthritis, Gouty arthritis, Psoriatic arthritis, Systemic lupus erythematosus, Bone TB, injuries and other systemic disorders etc.

Design outcomes

Primary

Measure	Time frame
Rasnadi guggul 500mg 2 tabs twice a day in the management of Sandhigat Vata (Osteoarthritis) for 45 daysTimepoint: Rasnadi guggul 500 mg 2tabs twice a day for 45 days	—

Secondary

Measure	Time frame
To assess the efficacy of shallaki in management of Sandhigat Vata ( Osteoarthritis)Timepoint: To assess the efficacy of Rasnadi guggul in the management of Sandhigat Vata ( Osteoarthritis) for duration of 45 days	—

Countries

India

Contacts

Public ContactDr Smita Gharge

CARC, Nigdi Pradhikaran, Pune

khobragaderupali19@gmail.com8378929859

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026